Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.7 |
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |